Ubiquoss Inc. (KOSDAQ:264450)
South Korea · Delayed Price · Currency is KRW 11,790
-380 (-3.12%)
At close: Jun 5, 2026
Ubiquoss Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 117,880 | 116,437 | 103,793 | 150,278 | 133,723 | 139,088 |
Other Revenue | 0.82 | 0.66 | 0.23 | 0.03 | - | -0 |
| 117,880 | 116,438 | 103,793 | 150,278 | 133,723 | 139,088 | |
Revenue Growth (YoY) | 20.12% | 12.18% | -30.93% | 12.38% | -3.86% | - |
Cost of Revenue | 67,888 | 67,800 | 66,078 | 90,649 | 85,520 | 83,957 |
Gross Profit | 49,992 | 48,638 | 37,715 | 59,629 | 48,203 | 55,131 |
Selling, General & Admin | 14,554 | 14,341 | 14,939 | 17,922 | 13,181 | 12,948 |
Research & Development | 10,028 | 9,609 | 8,700 | 10,994 | 9,399 | 9,526 |
Amortization of Goodwill & Intangibles | 344.37 | 344.37 | 344.37 | 345.47 | 15.26 | 13.76 |
Other Operating Expenses | 215.59 | 217.86 | 250.34 | 213.27 | 263.84 | 185.38 |
Operating Expenses | 26,110 | 25,534 | 25,344 | 30,590 | 23,661 | 23,279 |
Operating Income | 23,882 | 23,104 | 12,371 | 29,039 | 24,542 | 31,852 |
Interest Expense | -101.36 | -106.63 | -256.7 | -657.61 | -118.16 | -25.75 |
Interest & Investment Income | 4,421 | 4,547 | 4,996 | 4,367 | 1,900 | 1,022 |
Earnings From Equity Investments | -20.1 | -1.32 | -4.1 | - | - | -136.13 |
Currency Exchange Gain (Loss) | 141.8 | -403.87 | 513.37 | -198.37 | 1,874 | 1,493 |
Other Non Operating Income (Expenses) | -298.14 | -274.88 | 284.19 | -266.95 | 198.98 | -40.55 |
EBT Excluding Unusual Items | 28,025 | 26,864 | 17,904 | 32,283 | 28,397 | 34,164 |
Gain (Loss) on Sale of Investments | 5,958 | 1,997 | 45.11 | 480.19 | -403.87 | 2,456 |
Gain (Loss) on Sale of Assets | -1.86 | -1.86 | - | - | - | - |
Pretax Income | 33,981 | 28,859 | 17,949 | 32,764 | 27,993 | 36,620 |
Income Tax Expense | 6,048 | 4,806 | -3,331 | 6,874 | 6,507 | 7,817 |
Earnings From Continuing Operations | 27,933 | 24,053 | 21,280 | 25,890 | 21,486 | 28,803 |
Minority Interest in Earnings | 0.23 | 0.22 | 0.08 | 0 | - | - |
Net Income | 27,933 | 24,053 | 21,280 | 25,890 | 21,486 | 28,803 |
Net Income to Common | 27,933 | 24,053 | 21,280 | 25,890 | 21,486 | 28,803 |
Net Income Growth | 55.78% | 13.03% | -17.80% | 20.50% | -25.41% | - |
Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | 15 |
Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 15 | 15 |
Shares Change (YoY) | -1.33% | -1.70% | -1.12% | -1.01% | - | - |
EPS (Basic) | 1896.98 | 1627.04 | 1415.00 | 1702.24 | 1398.34 | 1874.57 |
EPS (Diluted) | 1896.98 | 1627.04 | 1415.00 | 1702.00 | 1398.34 | 1874.57 |
EPS Growth | 57.88% | 14.99% | -16.86% | 21.72% | -25.41% | - |
Free Cash Flow | 24,277 | 24,331 | 38,230 | 30,366 | 633.25 | 19,745 |
Free Cash Flow Per Share | 1648.70 | 1645.84 | 2542.04 | 1996.52 | 41.21 | 1285.06 |
Gross Margin | 42.41% | 41.77% | 36.34% | 39.68% | 36.05% | 39.64% |
Operating Margin | 20.26% | 19.84% | 11.92% | 19.32% | 18.35% | 22.90% |
Profit Margin | 23.70% | 20.66% | 20.50% | 17.23% | 16.07% | 20.71% |
Free Cash Flow Margin | 20.59% | 20.90% | 36.83% | 20.21% | 0.47% | 14.20% |
EBITDA | 27,113 | 26,416 | 15,960 | 32,610 | 27,490 | 34,279 |
EBITDA Margin | 23.00% | 22.69% | 15.38% | 21.70% | 20.56% | 24.65% |
D&A For EBITDA | 3,231 | 3,311 | 3,589 | 3,571 | 2,948 | 2,428 |
EBIT | 23,882 | 23,104 | 12,371 | 29,039 | 24,542 | 31,852 |
EBIT Margin | 20.26% | 19.84% | 11.92% | 19.32% | 18.35% | 22.90% |
Effective Tax Rate | 17.80% | 16.65% | - | 20.98% | 23.24% | 21.34% |
Advertising Expenses | - | 11.54 | 5 | 6.36 | 13.43 | 11.69 |